Study of WIN378 for moderate or severe asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests an investigational medicine called WIN378, given as an injection, to see if it is safe and helps control moderate or severe asthma. It may be an option for people whose asthma is not well controlled with their current inhalers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a doctor's diagnosis of asthma and proof that your airways open up after using a reliever inhaler, either in the last 2 years or during the study screening.
- Your lung function (measured by a breathing test) must be between 30% and 90% of normal for the first part, or between 30% and 80% for the second part.
- You must be on a daily inhaled steroid (like fluticasone or budesonide) and at least one other asthma controller medicine, such as a long-acting bronchodilator.
- For the second part, you must have had at least 2 asthma flare-ups (attacks) in the last 12 months.
- You cannot have other significant lung diseases, a history of tuberculosis, or have smoked 10 pack-years or more (e.g., 1 pack a day for 10 years).
- You must not have used certain biologic drugs, immunosuppressants, or live vaccines recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
This study tests a new investigational medicine called EB070 given as an injection to see if it's safe and helps control asthma better than a placebo. It is for adults with moderate-to-severe asthma who are already taking daily controllers.
This trial tests a new drug called IBI3002 for people with moderate to severe asthma that isn't well controlled with standard inhalers. It aims to see if the drug is safe and tolerable when given multiple times.
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
This study tests an investigational drug called AK139, given as an injection, to see if it can improve asthma control. It may be an option for people who have had asthma for at least a year and still have symptoms.
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.